GILEAD SCIENCES DL-,001

GIS XETRA / Francfort Healthcare & Biotech United States
113.72
1.68 %

Gilead Sciences is a biopharmaceutical company that develops and markets medicines for the treatment of infectious diseases, including HIV and hepatitis C.

Performance & Momentum

6 Months 7.34 %
1 Year 28.64 %
3 Years 77.32 %
5 Years 145.17 %

Similar stocks to GILEAD SCIENCES DL-,001

Anantys Community

Be the first to share your analysis on GILEAD SCIENCES DL-,001.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases